This article is an analysis of a cancer patient education programme run by cosmetic companies. I focus on an analysis of imagery, arguing that there are particular discursive elements that the cosmetic companies use in order to make productive the relationship between femininity and cancer. I contextualize this education programme by presenting the controversies regarding cosmetics as they relate to the growth of breast tumours. In doing so, I conclude that conversations and questions about a link between chemicals and cancer are subverted by both `horror' narratives of cancer and the provocative use of standards of beauty. Such discursive dominance in patient education programmes makes it difficult to engage in a more public understanding of cancer growth as affected by cosmetic chemicals.
Alderson, E. (1997). Ballet as ideology: Giselle, Act 2. In J. Desmond (Ed.), Meaning in motion: New cultural studies of dance, pp. 121-32. London: Duke University.
2.
Banks, M. (2001). Visual methods in social research. London: SAGE.
3.
Batchen, G. (2003). `Fearful ghost of former bloom': What photography is. In D. Green (Ed.), Where is the photograph, pp. 15-28. Brighton, UK: Photoforum and Photoworks.
4.
Bate, D. (2003). Art, education, photography. In L. Wells (Ed.), The photography reader , pp. 435-42. New York: Routledge.
5.
Belting, H. (1995). Gary Hill and the alphabet of images. In T. Vischer (Ed.), Gary Hill : Imagining the brain closer than the eyes, pp. 1-15. Ostfildern, Germany: Museum für Gegenwartskunst Basel .
6.
Beral, V. and Million Women Study Collaborators. (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362(9382), 419-27.
7.
Berger, J. (1977). Ways of seeing. London: Penguin.
8.
Bernstein, L. and Ross, R. (1993). Endogenous hormones and breast cancer risk. Epidemiological Review, 15(1), 48-65.
9.
Burdall, S., Hanby, A., Lansdown, M. and Speirs, V. (2003). Breast cancer cell lines: Friend or foe? Breast Cancer Research, 5(2), 89-95.
10.
Burgin, V. (2003). Looking at photographs. In L. Wells (Ed.), The photography reader, pp. 130-7. New York: Routledge.
11.
Byford, J.R., Shaw, L.E., Drew, M.G., Pope, G.S., Sauer, M.J. and Darbre, P.D. (2002). Oestrogenic activity of parabens in MCF7 human breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology, 80(1), 49-60.
12.
Callister, S. (2007). `Broken gargoyles': The photographic representation of severely wounded New Zealand soldiers. Social History of Medicine, 20(1), 111-30.
13.
Campany, D. (2003). Safety in numbness: Some remarks on problems of `late photography'. In D. Green (Ed.), Where is the photograph, pp. 120-32. Brighton, UK: Photoforum and Photoworks.
14.
Canadian Cancer Society/National Cancer Institute of Canada. (2007). Canadian cancer statistics 2007. Toronto: Canadian Cancer Society.
15.
Carpenter, J., Brockopp, D. and Andrykowski, M. (1999). Self-transformation as a factor in the self-esteem and well-being of breast cancer survivors. Journal of Advanced Nursing, 29(6), 1402-11.
16.
Carver, C., Lehman, J. and Antoni, M. (2003). Dispositional pessimism predicts illness-related disruption of social and recreational activities among breast cancer patients . Journal of Personality and Social Psychology, 84(4), 813-21.
17.
Chlebowski, R., Hendrix, S., Langer, R., Stefanick, M., Gass, M., Lane, D. et al. (2003). Influence of oestrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The women's health initiative randomized trial. Journal of the American Medical Association, 289(24), 3243-53.
18.
Clarke, J. and Everest, M. (2006). Cancer in the mass print media: Fear, uncertainty and the medical model. Social Science and Medicine, 62(10), 2591-600.
19.
Darbre, P. (2003). Underarm cosmetics and breast cancer. Journal of Applied Toxicology, 23(2), 89-95.
20.
Darbre, P., Aljarrah, A., Miller, W., Coldham, N., Sauer, M. and Pope, G. (2004). Concentrations of parabens in human breast tumors . Journal of Applied Toxicology, 24(1), 5-13.
21.
Ehrenreich, B. (2001). Welcome to cancer land: A mammogram leads to a cult of pink kitsch. Harpers Magazine, November, 43-53.
22.
Epstein, S. (2005). The Look Good …Feel Better Program: But at what risk? World-Wire, 3 November.
23.
Foucault, M. (1982). The subject and power. Critical Inquiry, 8(Summer), 777-95.
24.
Harvey, P. and Darbre, P. (2004). Endocrine disruptors and human health: Could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? A review of evidence and call for further research. Journal of Applied Toxicology, 24(3), 167-76.
25.
Hatch, E., Palmer, J., Titus-Ernstoff, L., Noller, K. and Kaufman, R. (1998). Cancer risk in women exposed to diethylstilbestrol in utero. Journal of the American Medical Association, 280(7), 630-4.
26.
Herbst, A. (1981). The current status of the DES-exposed population . Obstetrical Gynecological Annual, 10, 267-78.
27.
Herbst, A. and Anderson, D. (1990). Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Seminars in Surgical Oncology, 6(6), 343-6.
28.
Horwitz, R., Viscoli, C., Merino, M., Brennan, T., Flannery, J. and Robboy, S. (1988). Clear cell adenocarcinoma of the vagina and cervix: Incidence, undetected disease, and diethylstilbestrol. Journal of Clinical Epidemiology, 41(6), 593-7.
29.
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C. and Thun, M. (2006). Cancer statistics. Cancer Journal for Clinicians, 56(2), 106-30.
30.
Johnston, G. (1983). Health risks and effects of prenatal exposure to diethylstilbestrol. Journal of Family Practice, 16(1), 51-4.
31.
Kapur, G. (2001). Body language: The visual arts in contemporary India. Art Gallery of Ontario, Curator's Talk, 22 November.
32.
Kelsey, J. and Whittemore, A. (1994). Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary: A brief overview. Annals of Epidemiology, 4(2), 89-95.
33.
Kemp, M. and Wallace, M. (2000). Spectacular bodies: The art and science of the human body from Leonardo da Vinci to now. Los Angeles, CA: University of California Press.
34.
Lerner, B. (2003). The breast cancer wars: Hope, fear, and the pursuit of a cure in twentieth-century America. New York: Oxford University.
35.
Lesbians and Breast Cancer Project Team. ( 2004). Coming out about lesbians and cancer. Toronto: Ontario Breast Cancer Community Research Initiative .
36.
Lipworth, L. (1995). Epidemiology of breast cancer. European Journal of Cancer Prevention, 31(4), 7-30.
37.
Look Good, Feel Better. (2004). http://www.lookgoodfeelbetter.org/ (accessed 1 August 2007).
38.
Miller, W. (1996). Oestrogen and breast cancer. London: Chapman & Hall.
39.
Muff Christensen, M., Yousaf, U., Enghold, G. and Storm, H. (2006). Increased suicide risk among Danish women with non-melanoma skin cancer, 1971-1999. European Journal of Cancer Prevention, 15(3), 266-8.
40.
Parkin, D. and Fernàndez, L. (2006). Use of statistics to assess the global burden of breast cancer. The Breast Journal, 12(1), S70-S80.
41.
Patterson, J. (1987). The dread disease: Cancer and modern American culture. Cambridge: Harvard University .
42.
Pugazhendhi, D., Pope, G. and Darbre, P. (2005). Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines. Journal of Applied Toxicology, 25(4), 301-9.
43.
Roesch, S., Adams, L., Hines, A., Palmores, A., Vyas, P., Tran, C. et al. (2005). Coping with prostate cancer: A meta-analytic review. Journal of Behavioral Medicine, 28(3), 281-93.
44.
Rastogi, S. (2000). Analytical control of preservative labelling on skin creams. Contact Dermatology, 43(6), 339-43.
45.
Rosman, S. (2004). Cancer and stigma: Experience of patients with chemotherapy alopecia. Patient Education and Counselling, 52(3), 333-9.
46.
Ryan, K. (1975). Cancer risk and oestrogen use in menopause. New England Journal of Medicine, 293(23), 1199.
47.
Seale, C. (2001). Sporting cancer: Struggle language in news reports of people with cancer. Sociology of Health & Illness, 23(3), 308-29.
48.
Seale, C. (2002). Cancer heroics: A study of news reports with particular reference to gender. Sociology, 26(1), 107-26.
49.
Smith, D. (1975). Association of exogenous oestrogen and endometrial carcinoma. New England Journal of Medicine, 293(23), 1164.
50.
Sontag, S. (1977). On photography. New York: Penguin.
51.
Sontag, S. (2003). Photography within the humanities. In L. Wells (Ed.), The photography reader , pp. 59-66. New York: Routledge.
52.
Stacey, J. (1997). Teratologies: A cultural study of cancer. New York: Routledge.
53.
Stafford, B. (1991). Body criticism: Imaging the unseen in enlightenment art and medicine. Cambridge: Massachusetts Institute of Technology.
54.
Stiegelis, H., Hagedoorn, M., Sanderman, R., van der Zee, K., Buunk, B. and van den Bergh, A. (2003). Cognitive adaptation: A comparison of cancer patients and healthy references. British Journal of Health Psychology, 8(3), 303-18.
55.
Sturken, M. and Cartwright, L. (2003). Practices of looking: An introduction to visual culture. New York: Oxford University .
56.
Tarlach, G. (2002). Not pink: A young woman facing breast cancer sees red when she's told to `think pink'. Milwaukee Journal Sentinel , 13 October.
57.
Thomson, R. (1997). Extraordinary bodies: Figuring physical disability in American culture and literature. New York: Columbia University.
58.
Thornton, A. (2002). Perceiving benefits in the cancer experience. Journal of Clinical Psychology in Medical Settings, 9(2), 153-65.
59.
Titus-Ernstoff, L., Hartch, E., Hoover, R., Palmer, J. and Greenberg, E. (2001). Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. British Journal of Cancer, 84(1), 125-33.
60.
Toon, E. (2007). Cancer as the general population knows it: Knowledge, fear, and lay education in 1950s Britain. Bulletin of the History of Medicine, 81(1), 116-38.
61.
Wendell, S. (1996). The rejected body: Feminist philosophical reflections on disability. New York: Routledge .
62.
Winer, E. (2005). Optimizing endocrine therapy for breast cancer . Journal of Clinical Oncology, 23(8), 1609-10.
